David A. Siegel Liva Nova PLC Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 86,345 shares of LIVN stock, worth $4.32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
86,345
Previous 99,645
13.35%
Holding current value
$4.32 Million
Previous $5.46 Million
17.01%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding LIVN
# of Institutions
261Shares Held
53MCall Options Held
316KPut Options Held
127K-
Black Rock Inc. New York, NY6.9MShares$346 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.63MShares$282 Million0.22% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.96MShares$148 Million0.08% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.09MShares$105 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$104 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.68B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...